1. Aledo-Serrano Á, Mingorance A, Villanueva V, et al. The Charlotte Project: Recommendations for patient-reported outcomes and clinical parameters in Dravet syndrome through a qualitative and Delphi consensus study. Front Neurol. 2022;13:975034. doi:10.3389/fneur.2022.975034
2. Balestrini S, Guerrini R, Sisodiya SM. Rare and complex epilepsies from childhood to adulthood: Requirements for separate management or scope for a lifespan holistic approach? Curr Neurol Neurosci Rep. 2021;21:65. doi:10.1007/s11910-021-01154-7
3. Beltrán-Corbellini Á, Aledo-Serrano Á, Møller RS, et al. Epilepsy genetics and precision medicine in adults: A new landscape for developmental and epileptic encephalopathies. Front Neurol. 2022;13:777115. doi:10.3389/fneur.2022.777115
4. Berg AT, Kaiser K, Dixon-Salazar T, et al. Seizure burden in severe early-life epilepsy: Perspectives from parents. Epilepsia Open. 2019;4(2):293-301. doi:10.1002/epi4.12319
5. Crudgington H, Collingwood A, Bray L, et al. Mapping epilepsy-specific patient-reported outcome measures for children to a proposed core outcome set for childhood epilepsy. Epilepsy Behav. 2020;112:107372. doi:10.1016/j.yebeh.2020.107372
6. Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: A 30-year longitudinal cohort study. JAMA Neurol. 2018;75:279-286. doi:10.1001/jamaneurol.2017.3949
7. Guerrini R, Conti V, Mantegazza M, Balestrini S, Galanopoulou AS, Benfenati F. Developmental and epileptic encephalopathies: From genetic heterogeneity to phenotypic continuum. Physiol Rev. 2023;103:433-513. doi:10.1152/physrev.00063.2021
8. Kalilani L, Faught E, Kim H, et al. Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US. Neurology. 2019;92:e2197-e2208. doi:10.1212/WNL.0000000000007448
9. Nariai H, Duberstein S, Shinnar S. Treatment of epileptic encephalopathies: Current state of the art. J Child Neurol. 201833:41-54. doi:10.1177/0883073817690290
10. Raga S, Specchio N, Rheims S, Wilmshurst JM. Developmental and epileptic encephalopathies: Recognition and approaches to care. Epileptic Disord. 2021;23:40-52. doi:10.1684/epd.2021.1244
11. Scheffer IE, Dravet C. Transition to adult life in the monogenic epilepsies. Epilepsia. 2014;55(suppl 3):12-15. doi:10.1111/epi.12707
12. Sorin LM, Knupp KG, Berg AT. New-onset seizure survey of epilepsy centers in the United States. Epilepsy Behav. 2019;101(Pt A):106579. doi:10.1016/j.yebeh.2019.106579
13. Syrbe S. Developmental and epileptic encephalopathies – therapeutic consequences of genetic testing. Med Genet. 2022;34:215-224. doi:10.1515/medgen-2022-2145
14. Zack MM, Kobau R. National and state estimates of the numbers of adults and children with active epilepsy – United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:821-825. doi:10.15585/mmwr.mm6631a1

All URLs accessed August 17, 2024